European Harm Reduction Conference

Stay up to date with all of the information regarding the European Harm Reduction Conference. Find here the program, abstracts, and more!

VISIT EHRC SITE

Civil Society Involvement in Drug Policy

Last Monday the 5th of November, the CSIDP Conference took place at the facilities of the European Commission. Find here more information about the program, the presentations, and read the first ever assessment report.

VISIT CSIDP WEBSITE

Aging Drug Users

The total number and proportion of older chronic people who use drugs in Europe have increased significantly meanwhile specialized treatment and care programs remain rare. Discover more information about this topic, and about our project BETRAD.

VISIT BETRAD SITE

HCV Community Summit

On September the 15th of October, the HCV Community Summit brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss and to develop an enduring cooperation for building the road to HCV elimination.

VISIT HCV COMMUNITY SUMMIT SITE

What does Harm Reduction mean to you, Anya Sarang?

 

Correlation Network advocates for a broader understanding and definition of Harm Reduction. The campaign “What does harm reduction mean to you?” is a visual testimony of different actors in the field. We want to share the diversity of understandings and the impact of harm reduction on our community.
And also to know, what it means to you?

 

HCV Testing in the Community

Correlation Network’s Hepatitis C works to reduce the burden of HCV among people who use drugs by promoting universal access to HCV prevention, treatment and care through collaborative action of research, advocacy and civil society strengthening. Find in here our materials and infosheets for HCV testing in the community.

VISIT WEBSITE: HCV TESTING IN THE COMMUNITY

Get Involved

Send us your reports, materials, information you want to share with Correlation and harm reduction organisations in Europe.

Conference – Civil Society Involvement in Drug Policy

The CSIDP Conference will bring civil society organisations, national and European policy makers, and other stakeholders to discuss the importance of civil society’s involvement in drug policy for the first time. The conference will present the level of participation in European Member States, provide models of good practice and critically discuss potential bottlenecks and shortcomings. The following questions will be addressed: Why is civil society involvement important? What has been achieved so far? How can civil society’s involvement be improved? What are the main principles for meaningful participation, and what is needed at the European, national, and local levels?

The two Civil Society Fora – the one on Drugs and the one on HIV, Hepatitis and Tuberculosis – will present their activities on European and international levels. Relevant stakeholders, including governmental officials and civil society representatives, will share different approaches and perspectives. Interactive sessions will enable the participants to discuss civil society’s role and limitations and inspire each other to improve cooperation and the dialogue between civil society and policymakers.

Presentations:
Civil Society Involvement at the UN Level. Does it work? – Jamie Bridge [IDPC]
Funding Gap in Romania – Alina Bocai [ARAS]
Promoting Democracy, Improving Government, Renewing Trust – Lucy McTernan [OGP]
Encouraging Examples in Drug Policy – Manuel Cardoso [SICAD]
Roadmap Presentation – Marcus Keane [ALDP]
Assessment Report – Harald Lahuse, Marcus Martnes ,Uwe Verthein [ZIS Hamburg]